-
Mix Sector Stocks News: Riverbed Technology (NASDAQ:RVBD), Biocept (NASDAQ:BIOC), Swift Transportation Company (NYSE:SWFT), Actavis plc (NYSE:ACT), Amazon.com (NASDAQ:AMZN)
An investor who currently holds shares of Riverbed Technology, Inc. (NASDAQ:RVBD), filed a lawsuit in effort to halt the proposed takeover of Riverbed Technology, Inc. by Thoma Bravo, LLC and Teachers’ Private Capital, the private investor department of Ontario Teachers’ Pension Plan for $21 per share. Riverbed Technology, Inc. (NASDAQ:RVBD) in last trading activity moved…
-
Stocks Getting Hot: Twitter Inc (NYSE:TWTR), Biocept (NASDAQ:BIOC), Origin Agritech Limited (NASDAQ:SEED), Cleco Corporation (NYSE:CNL), Renewable Energy Group (NASDAQ:REGI)
Twitter Inc (NYSE:TWTR) VP Kevin Weil sold 3,587 shares of the stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $37.87, for a total transaction of $135,839.69. Following the transaction, the vice president now directly owns 998,357 shares in the company, valued at approximately $37,807,780.…
-
Market Movers: Intel Corporation (NASDAQ:INTC), Biocept (NASDAQ:BIOC), Arena Pharmaceuticals (NASDAQ:ARNA), LDR Holding Corporation (NASDAQ:LDRH), REEDS (NYSEMKT:REED)
At the International Consumer Electronics Show (CES) 2015, Intel Corporation (NASDAQ:INTC) announced that it will increase the number of women and minority workers as part of its plan to create a more diverse global workforce over the next five years. On Friday shares of Intel Corporation (NASDAQ:INTC) closed at $36.76. Company’s sales growth for last…
-
Big Movers: Teva Pharmaceutical Industries Limited (NYSE:TEVA), Groupon (NASDAQ:GRPN), Biocept (NASDAQ:BIOC), CGG SA (ADR) (NYSE:CGG), Inogen (NASDAQ:INGN)
Teva Pharmaceutical Industries Limited (NYSE:TEVA). said Wednesday it has received Food and Drug Administration approval for a generic version of the high blood pressure medicine Diovan. Teva has since launched the medication. Teva Pharmaceutical Industries Limited (NYSE:TEVA) in last trading activity increased 4.17% to close at $57.22. Company weekly performance is 0.44% while its quarterly…
-
Hot Runners: Johnson & Johnson (NYSE:JNJ), Bitauto Holdings Limited (NYSE:BITA), EMCORE Corporation (NASDAQ:EMKR), Biocept (NASDAQ:BIOC), pSivida Corp. (NASDAQ:PSDV)
Johnson & Johnson (NYSE:JNJ) will participate in the 33rd Annual JP Morgan Health Care Conference on Monday, Jan. 12, at the Westin St. Francis in San Francisco. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer, will represent the Company in a session scheduled at 10:30 a.m. (Pacific Time)/1:30 p.m. (Eastern Time).…
-
Mix Sector Stocks: Ford Motor Company (NYSE:F), The Habit Restaurants (NASDAQ:HABT), Biocept (NASDAQ:BIOC), Can-Fite BioPharma (NYSEMKT:CANF), Wolverine World Wide (NYSE:WWW)
US auto major Ford Motor Company (NYSE:F) will recall more than 20,700 units of its top selling model in India, the EcoSport compact sport-utility vehicle, to fix what it said an airbag issue and faulty fuel line. Ford Motor Company (NYSE:F) in last trading activity fell -1.33% to close at $14.09. Company weekly performance is…
-
Market Alert: Valero Energy Corporation (NYSE:VLO), HomeAway (NASDAQ:AWAY), OPOWER (NYSE:OPWR), Cardiovascular Systems Inc. (NASDAQ:CSII), Biocept (NASDAQ:BIOC)
On 12 November Valero Energy Corporation (NYSE:VLO) reported third quarter 2014 net income of $17.5 million, or $0.30 per limited partner unit. The Partnership generated earnings before interest, income taxes, depreciation, and amortization (EBITDA) of $22.2 million and distributable cash flow of $21.1 million. The Partnership’s coverage ratio for the third quarter of 2014 was…
-
Healthcare Gainers: Bio Blast Pharma (NASDAQ:ORPN), Coronado Biosciences (NASDAQ:CNDO), RXi Pharmaceuticals Corporation (NASDAQ:RXII), NephroGenex (NASDAQ:NRX), Biocept (NASDAQ:BIOC)
Bio Blast Pharma Ltd. (NASDAQ:ORPN) on 19 November announced it has been granted Orphan Drug Designation by the U.S. FDA for Cabaletta for the treatment of Spinocerebellar Ataxia Type 3 (known as SCA3 and Machado Joseph disease). This is the second indication for which Bio Blast’s Cabaletta has received such designation.Bio Blast Pharma Ltd. (NASDAQ:ORPN)…
-
Why Making Dramatic Moves: Biocept (NASDAQ:BIOC), Host Hotels & Resorts (NYSE:HST), International Speedway Corp. (NASDAQ:ISCA), ePlus inc. (NASDAQ:PLUS), Jamba (NASDAQ:JMBA)
On Nov. 13, Biocept, Inc. (NASDAQ:BIOC) announced its financial results for the third quarter ended September 30, 2014. Revenues were approximately $10,000 for the third quarter of 2014, compared with approximately $32,000 for the same period in 2013. Biocept, Inc. (NASDAQ:BIOC) in last trading activity moved down -11.04% to close at $2.90. Company weekly performance…